Fig. 1: Number of agents applied as second-line treatment in multiple myeloma patients, initiation of second-line treatment 2003–2021.
From: Second- and third-line treatment strategies in multiple myeloma: a referral-center experience
ASCT autologous stem cell transplantation.
